These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Pathogenesis and therapy of ascites in liver cirrhosis]. Janssens AR; van Brummelen P Ned Tijdschr Geneeskd; 1980 Jul; 124(28):1156-9. PubMed ID: 7402394 [No Abstract] [Full Text] [Related]
7. Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failure. Moreau R; Gaudin C; Hadengue A; Braillon A; Roulot D; Bacq Y; Lebrec D Nephron; 1993; 65(3):359-63. PubMed ID: 8289984 [TBL] [Abstract][Full Text] [Related]
9. [The ascitic syndrome in hepatic cirrhosis. (Clinical physiopathology)]. Galea G Med Interna (Bucur); 1968 Apr; 20(4):389-96. PubMed ID: 5735411 [No Abstract] [Full Text] [Related]
10. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis]. Bondarenko IP; Dubinskiĭ AA; Tereshkin IG Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578 [TBL] [Abstract][Full Text] [Related]
11. Hyperdynamic circulation of advanced cirrhosis: a re-appraisal based on posture-induced changes in hemodynamics. Bernardi M; Fornalè L; Di Marco C; Trevisani F; Baraldini M; Gasbarrini A; De Collibus C; Zacà F; Ligabue A; Colantoni A J Hepatol; 1995 Mar; 22(3):309-18. PubMed ID: 7608482 [TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Wong F; Sniderman K; Liu P; Allidina Y; Sherman M; Blendis L Ann Intern Med; 1995 Jun; 122(11):816-22. PubMed ID: 7741365 [TBL] [Abstract][Full Text] [Related]
13. Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems. Bernardi M; Gulberg V; Colantoni A; Trevisani F; Gasbarrini A; Gerbes AL J Hepatol; 1996 Feb; 24(2):161-8. PubMed ID: 8907569 [TBL] [Abstract][Full Text] [Related]
14. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229 [TBL] [Abstract][Full Text] [Related]
15. Portal and systemic hemodynamics and humoral factors in cirrhosis with and without ascites. Hayes PC; Cumming AD; Craig KJ; Watson M; Bouchier IA Am J Gastroenterol; 1992 Oct; 87(10):1433-8. PubMed ID: 1415100 [TBL] [Abstract][Full Text] [Related]
16. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction. Nazar A; Guevara M; Sitges M; Terra C; Solà E; Guigou C; Arroyo V; Ginès P J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573 [TBL] [Abstract][Full Text] [Related]
17. [Significances of plasma levels of neuropeptide Y pre- and post-treatment in patients with decompensated cirrhosis and ascites]. Li GW; Wu LD; Zhu Y Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):483-4. PubMed ID: 12754138 [TBL] [Abstract][Full Text] [Related]
18. [Negative influences of ascitic effusion on cardiac function in cirrhotics]. Guazzi M; Polese A; Magrini F; Fiorentini C; Olivari MT Boll Soc Ital Cardiol; 1975; 20(10):1359-67. PubMed ID: 1234435 [No Abstract] [Full Text] [Related]
19. Pathogenesis of ascites in cirrhosis and portal hypertension. Heneghan MA; Harrison PM Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415 [TBL] [Abstract][Full Text] [Related]